.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Johnson and Johnson
Farmers Insurance
Chinese Patent Office
Moodys
Covington
Express Scripts
Cipla
Cantor Fitzgerald

Generated: January 16, 2018

DrugPatentWatch Database Preview

Patents Expiring in March 2030

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-003Apr 5, 2010RXYesNo➤ Subscribe➤ SubscribeY
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-002Apr 5, 2010RXYesNo➤ Subscribe➤ SubscribeY
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-001Apr 5, 2010RXYesNo➤ Subscribe➤ SubscribeY
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-004Apr 5, 2010RXYesNo➤ Subscribe➤ SubscribeY
Indivior IncSUBOXONEbuprenorphine hydrochloride; naloxone hydrochlorideFILM;BUCCAL, SUBLINGUAL022410-004Aug 10, 2012RXYesYes➤ Subscribe➤ SubscribeYTHIS DRUG IS ADMINISTERED BY SUBLINGUAL ROUTE TO HUMANS FOR MAINTENANCE TREATMENT OF OPIOID DEPENDENCE
Indivior IncSUBOXONEbuprenorphine hydrochloride; naloxone hydrochlorideFILM;BUCCAL, SUBLINGUAL022410-002Aug 30, 2010RXYesNo➤ Subscribe➤ SubscribeYTHIS DRUG IS ADMINISTERED BY SUBLINGUAL ROUTE TO HUMANS FOR MAINTENANCE TREATMENT OF OPIOID DEPENDENCE
Indivior IncSUBOXONEbuprenorphine hydrochloride; naloxone hydrochlorideFILM;BUCCAL, SUBLINGUAL022410-003Aug 10, 2012RXYesNo➤ Subscribe➤ SubscribeYTHIS DRUG IS ADMINISTERED BY SUBLINGUAL ROUTE TO HUMANS FOR MAINTENANCE TREATMENT OF OPIOID DEPENDENCE
Indivior IncSUBOXONEbuprenorphine hydrochloride; naloxone hydrochlorideFILM;BUCCAL, SUBLINGUAL022410-001Aug 30, 2010RXYesNo➤ Subscribe➤ SubscribeYTHIS DRUG IS ADMINISTERED BY SUBLINGUAL ROUTE TO HUMANS FOR MAINTENANCE TREATMENT OF OPIOID DEPENDENCE
MannkindAFREZZAinsulin recombinant humanPOWDER;INHALATION022472-003Apr 17, 2015RXYesNo➤ Subscribe➤ SubscribeY
MannkindAFREZZAinsulin recombinant humanPOWDER;INHALATION022472-002Jun 27, 2014RXYesYes➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
AstraZeneca
Colorcon
Chubb
Healthtrust
Medtronic
Chinese Patent Office
Covington
US Army
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot